PLoS ONE 2012-01-01

Granzyme B-induced neurotoxicity is mediated via activation of PAR-1 receptor and Kv1.3 channel.

Tongguang Wang, Myoung-Hwa Lee, Elliot Choi, Carlos A Pardo-Villamizar, Sung Bin Lee, In Hong Yang, Peter A Calabresi, Avindra Nath

文献索引:PLoS ONE 7(8) , e43950, (2012)

全文:HTML全文

摘要

Increasing evidence supports a critical role of T cells in neurodegeneration associated with acute and subacute brain inflammatory disorders. Granzyme B (GrB), released by activated T cells, is a cytotoxic proteinase which may induce perforin-independent neurotoxicity. Here, we studied the mechanism of perforin-independent GrB toxicity by treating primary cultured human neuronal cells with recombinant GrB. GrBactivated the protease-activated receptor (PAR)-1 receptor on the neuronal cell surface leading to decreased intracellular cyclic AMP levels. This was followed by increased expression and translocation of the voltage gated potassium channel, Kv1.3 to the neuronal cell membrane. Similar expression of Kv1.3 was also seen in neurons of the cerebral cortex adjacent to active inflammatory lesions in patients with multiple sclerosis. Kv1.3 expression was followed by activation of Notch-1 resulting in neurotoxicity. Blocking PAR-1, Kv1.3 or Notch-1 activation using specific pharmacological inhibitors or siRNAs prevented GrB-induced neurotoxicity. Furthermore, clofazimine protected against GrB-induced neurotoxicity in rat hippocampus, in vivo. These observations indicate that GrB released from T cells induced neurotoxicity by interacting with the membrane bound Gi-coupled PAR-1 receptor and subsequently activated Kv1.3 and Notch-1. These pathways provide novel targets to treat T cell-mediated neuroinflammatory disorders. Kv1.3 is of particular interest since it is expressed on the cell surface, only under pathological circumstances, and early in the cascade of events making it an attractive therapeutic target.


相关化合物

  • 氯苯吩嗪
  • 钾离子荧光探针

相关文献:

The efflux pump inhibitor timcodar improves the potency of antimycobacterial agents.

2015-03-01

[Antimicrob. Agents Chemother. 59(3) , 1534-41, (2015)]

Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis.

2015-01-20

[Proc. Natl. Acad. Sci. U. S. A. 112(3) , 869-74, (2015)]

Anticancer efficacy and toxicokinetics of a novel paclitaxel-clofazimine nanoparticulate co-formulation.

2015-06-01

[Drug Deliv Transl Res 5 , 257-67, (2015)]

Clofazimine Induced Suicidal Death of Human Erythrocytes.

2015-01-01

[Cell Physiol. Biochem. 37 , 331-41, (2015)]

State-dependent blocking mechanism of Kv 1.3 channels by the antimycobacterial drug clofazimine.

2015-11-01

[Br. J. Pharmacol. 172 , 5161-73, (2015)]

更多文献...